Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 19.5
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. Its services include Discovery Toxicology, Agro-Chemicals and Chemical Safety, Biocompatibility Studies, Diet Formulation and Batch Release Test. The company was founded on April 29, 2016 and is headquartered in Hyderabad, India.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers.
Data is available to registered users only
Buy
Sell